Published in J Neurosurg Pediatr on January 10, 2014
Editorial: Convection-enhanced delivery for diffuse intrinsic pontine glioma. J Neurosurg Pediatr (2014) 1.07
Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment. Curr Neuropharmacol (2017) 0.76
Re-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas: A Review. Curr Neuropharmacol (2017) 0.75
Response. J Neurosurg Pediatr (2014) 0.75
A novel in situ permeation system and its utility in cancer tissue ablation. Int J Oncol (2015) 0.75
MRI contrast agent for targeting glioma: interleukin-13 labeled liposome encapsulating gadolinium-DTPA. Neuro Oncol (2015) 0.75
Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets. Curr Neuropharmacol (2017) 0.75
Drug-carrying microbubbles as a theranostic tool in convection-enhanced delivery for brain tumor therapy. Oncotarget (2017) 0.75
Simulating vasogenic brain edema using chronic VEGF infusion. J Neurosurg (2017) 0.75
OsiriX: an open-source software for navigating in multidimensional DICOM images. J Digit Imaging (2004) 11.92
Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A (1994) 6.61
Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat Med (1997) 2.76
Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. J Neurosurg (1999) 1.97
Effect of concentration on the accuracy of convective imaging distribution of a gadolinium-based surrogate tracer. J Neurosurg (2011) 1.87
Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion. J Neurosurg (2002) 1.79
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol (2010) 1.78
Intracerebral clysis in a rat glioma model. Neurosurgery (2000) 1.77
Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning. Neurosurgery (2007) 1.74
Poor drug distribution as a possible explanation for the results of the PRECISE trial. J Neurosurg (2010) 1.65
Image-guided, direct convective delivery of glucocerebrosidase for neuronopathic Gaucher disease. Neurology (2006) 1.57
Direct convective delivery of macromolecules to the spinal cord. J Neurosurg (1998) 1.53
Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note. J Neurosurg (2007) 1.51
Direct interstitial infusion of NK1-targeted neurotoxin into the spinal cord: a computational model. Am J Physiol Regul Integr Comp Physiol (2003) 1.50
Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions. Neuro Oncol (2007) 1.39
Direct convective delivery of macromolecules to peripheral nerves. J Neurosurg (1998) 1.35
Novel platform for MRI-guided convection-enhanced delivery of therapeutics: preclinical validation in nonhuman primate brain. Stereotact Funct Neurosurg (2011) 1.30
Image-guided convection-enhanced delivery of muscimol to the primate brain. J Neurosurg (2010) 1.29
Real-time in vivo imaging of the convective distribution of a low-molecular-weight tracer. J Neurosurg (2005) 1.17
Effect of ependymal and pial surfaces on convection-enhanced delivery. J Neurosurg (2008) 1.17
Convection-enhanced delivery of free gadolinium with the recombinant immunotoxin MR1-1. J Neurooncol (2009) 1.11
Convective delivery of glial cell line-derived neurotrophic factor in the human putamen. J Neurosurg (2007) 1.11
Convection perfusion of glucocerebrosidase for neuronopathic Gaucher's disease. Ann Neurol (2005) 1.08
Colocalization of gadolinium-diethylene triamine pentaacetic acid with high-molecular-weight molecules after intracerebral convection-enhanced delivery in humans. Neurosurgery (2011) 1.08
Image-guided convection-enhanced delivery of GDNF protein into monkey putamen. Neuroimage (2010) 1.02
Safety and tolerability of magnetic resonance imaging-guided convection-enhanced delivery of AAV2-hAADC with a novel delivery platform in nonhuman primate striatum. Hum Gene Ther (2012) 1.02
Canine spontaneous glioma: a translational model system for convection-enhanced delivery. Neuro Oncol (2010) 0.97
Convection-enhanced delivery of liposomes to primate brain. Methods Enzymol (2009) 0.96
Convective delivery of macromolecules into the naive and traumatized spinal cords of rats. J Neurosurg (1999) 0.96
A computational model of direct interstitial infusion of macromolecules into the spinal cord. Ann Biomed Eng (2003) 0.93
Interstitial infusion of carmustine in the rat brain stem with systemic administration of O6-benzylguanine. J Neurooncol (2004) 0.89
Interstitial infusion of IL13-PE38QQR in the rat brain stem. J Neurooncol (2004) 0.87
Comparison of pulsed versus continuous convective flow for central nervous system tissue perfusion: laboratory investigation. J Neurosurg (2012) 0.82
Posterior subtemporal transtentorial approach to intraparenchymal lesions of the anteromedial region of the superior cerebellum. J Neurosurg (2005) 2.69
Effect of pregnancy on hemangioblastoma development and progression in von Hippel-Lindau disease. J Neurosurg (2012) 2.65
The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg (2003) 2.34
Neurofibromatosis type 2. Lancet (2009) 2.24
Effect of concentration on the accuracy of convective imaging distribution of a gadolinium-based surrogate tracer. J Neurosurg (2011) 1.87
Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms. J Neurosurg (2013) 1.86
Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel-Lindau disease. JAMA (2007) 1.73
Retracted Application and implementation of selective tissue microdissection and proteomic profiling in neurological disease. Neurosurgery (2009) 1.69
Real-time imaging of convection-enhanced delivery of viruses and virus-sized particles. J Neurosurg (2007) 1.68
Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors. J Neurosurg (2012) 1.59
Metastases to hemangioblastomas in von Hippel-Lindau disease. J Neurosurg (2006) 1.58
Long-term natural history of hemangioblastomas in patients with von Hippel-Lindau disease: implications for treatment. J Neurosurg (2006) 1.55
von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells. PLoS Med (2007) 1.52
Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note. J Neurosurg (2007) 1.51
Direct interstitial infusion of NK1-targeted neurotoxin into the spinal cord: a computational model. Am J Physiol Regul Integr Comp Physiol (2003) 1.50
Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease. Mol Ther (2011) 1.50
Reversal of cerebral vasospasm via intravenous sodium nitrite after subarachnoid hemorrhage in primates. J Neurosurg (2011) 1.47
Convection-enhanced delivery of M13 bacteriophage to the brain. J Neurosurg (2012) 1.42
Cochlear implantation for hearing loss associated with bilateral endolymphatic sac tumors in von Hippel-Lindau disease. Otol Neurotol (2007) 1.41
Philanthropy funding for neurosurgery research and program development. Neurosurgery (2013) 1.40
The history of pituitary surgery for Cushing disease. J Neurosurg (2011) 1.38
Developmental arrest of angioblastic lineage initiates tumorigenesis in von Hippel-Lindau disease. Cancer Res (2003) 1.38
Hemangioblastomas share protein expression with embryonal hemangioblast progenitor cell. Cancer Res (2006) 1.34
Expression of interleukin-13 receptor alpha2 in glioblastoma multiforme: implications for targeted therapies. Cancer Res (2007) 1.33
Association of human herpesvirus-6B with mesial temporal lobe epilepsy. PLoS Med (2007) 1.32
Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats. J Neurosurg (2003) 1.30
Immunologic privilege in the central nervous system and the blood-brain barrier. J Cereb Blood Flow Metab (2012) 1.30
Image-guided convection-enhanced delivery of muscimol to the primate brain. J Neurosurg (2010) 1.29
Neurologic manifestations of von Hippel-Lindau disease. JAMA (2008) 1.26
Real-time, image-guided, convection-enhanced delivery of interleukin 13 bound to pseudomonas exotoxin. Clin Cancer Res (2006) 1.23
Surgical management of brainstem hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg (2003) 1.21
Pathophysiology of headache associated with cough in patients with Chiari I malformation. J Neurosurg (2003) 1.20
Safety and feasibility of long-term intravenous sodium nitrite infusion in healthy volunteers. PLoS One (2011) 1.19
Real-time in vivo imaging of the convective distribution of a low-molecular-weight tracer. J Neurosurg (2005) 1.17
Effect of ependymal and pial surfaces on convection-enhanced delivery. J Neurosurg (2008) 1.17
Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease. Neuro Oncol (2009) 1.17
Image-guided convection-enhanced delivery of gemcitabine to the brainstem. J Neurosurg (2007) 1.17
Management of von Hippel-Lindau disease-associated CNS lesions. Expert Rev Neurother (2011) 1.16
Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function. Proc Natl Acad Sci U S A (2011) 1.13
Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease: implications for their natural history, diagnosis, and treatment. J Neurosurg (2005) 1.13
Effects of VHL deficiency on endolymphatic duct and sac. Cancer Res (2005) 1.11
Convective delivery of glial cell line-derived neurotrophic factor in the human putamen. J Neurosurg (2007) 1.11
Decreased glucocerebrosidase activity in Gaucher disease parallels quantitative enzyme loss due to abnormal interaction with TCP1 and c-Cbl. Proc Natl Acad Sci U S A (2010) 1.09
Therapeutic targeting based on gene-expression profiling in vestibular schwannomas. J Neurosurg (2014) 1.07
Histone deacetylase inhibitors prevent the degradation and restore the activity of glucocerebrosidase in Gaucher disease. Proc Natl Acad Sci U S A (2011) 1.06
Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg (2008) 1.06
Time course of syringomyelia resolution following decompression of Chiari malformation Type I. J Neurosurg Pediatr (2008) 1.03
Selective ablation of nociceptive neurons for elimination of hyperalgesia and neurogenic inflammation. J Neurosurg (2005) 1.03
In-training factors predictive of choosing and sustaining a productive academic career path in neurological surgery. Neurosurgery (2012) 1.03
Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging. Neuro Oncol (2011) 1.02
Infratentorial craniospinal irradiation for von Hippel-Lindau: a retrospective study supporting a new treatment for patients with CNS hemangioblastomas. Neuro Oncol (2011) 1.02
Symptomatic epidural hematoma caused by lumbar synovial cyst rupture: report of two cases and review of the literature. Neurosurgery (2005) 1.02
Inter-observer variability in the measurement of diffuse intrinsic pontine gliomas. J Neurooncol (2008) 1.02
Endolymphatic sac tumor demonstrated by intralabyrinthine hemorrhage. Case report. J Neurosurg (2007) 1.02
Functional outcome after resection of spinal cord hemangioblastomas associated with von Hippel-Lindau disease. J Neurosurg Spine (2010) 1.02
The effect of a PP2A inhibitor on the nuclear receptor corepressor pathway in glioma. J Neurosurg (2010) 1.01
Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: findings, results, and indications. Laryngoscope (2012) 0.98
Intraoperative infrared imaging of brain tumors. J Neurosurg (2004) 0.98
Angiogenic factors stimulate growth of adult neural stem cells. PLoS One (2010) 0.98
Convection-enhanced delivery for the treatment of pediatric neurologic disorders. J Child Neurol (2008) 0.98
β-Catenin signaling initiates the activation of astrocytes and its dysregulation contributes to the pathogenesis of astrocytomas. Proc Natl Acad Sci U S A (2012) 0.96
Proteostasis modulators prolong missense VHL protein activity and halt tumor progression. Cell Rep (2013) 0.96
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy? Neuroimage (2010) 0.95
Somatic mutations in VHL germline deletion kindred correlate with mild phenotype. Ann Neurol (2004) 0.94
A computational model of direct interstitial infusion of macromolecules into the spinal cord. Ann Biomed Eng (2003) 0.93
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med (2015) 0.91
Surgical management of melanoma brain metastases in patients treated with immunotherapy. J Neurosurg (2011) 0.91
Concept of arteriovenous malformation compartments and surgical management. Neurol Res (2004) 0.91
The lateralization accuracy of inferior petrosal sinus sampling in 501 patients with Cushing's disease. J Clin Endocrinol Metab (2013) 0.91
Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma. Acta Neuropathol Commun (2014) 0.89
Neuronatin in a subset of glioblastoma multiforme tumor progenitor cells is associated with increased cell proliferation and shorter patient survival. PLoS One (2012) 0.88
Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma. J Neurooncol (2011) 0.88
Insertion of mutant proteolipid protein results in missorting of myelin proteins. Ann Neurol (2003) 0.88
Proteomic analysis of hemangioblastoma cyst fluid. Cancer Biol Ther (2006) 0.87
Real-time detection of vascular occlusion and reperfusion of the brain during surgery by using infrared imaging. J Neurosurg (2002) 0.87
Unclear standard of care for pediatric high grade glioma patients. J Neurooncol (2013) 0.86
Pharmacokinetics of temozolomide administered in combination with O6-benzylguanine in children and adolescents with refractory solid tumors. Cancer Chemother Pharmacol (2009) 0.86
Hemangioblastoma-associated mast cells in von Hippel-Lindau disease are tumor derived. Blood (2013) 0.86
Long-term outcome after resection of brainstem hemangioblastomas in von Hippel-Lindau disease. J Neurosurg (2010) 0.86
Mechanisms of hearing loss in neurofibromatosis type 2. PLoS One (2012) 0.85
Cholera toxin regulates a signaling pathway critical for the expansion of neural stem cell cultures from the fetal and adult rodent brains. PLoS One (2010) 0.85
Developmentally arrested structures preceding cerebellar tumors in von Hippel-Lindau disease. Mod Pathol (2011) 0.84
Second hit deletion size in von Hippel-Lindau disease. Ann Neurol (2006) 0.84
Von hippel-lindau disease associated pulmonary carcinoid with cranial metastasis. J Clin Endocrinol Metab (2014) 0.83
A von Hippel-Lindau disease-associated microcystic adenoma of the ethmoid sinus: case report. Neurosurgery (2011) 0.83
Cortical mapping and frameless stereotactic navigation in the high-field intraoperative magnetic resonance imaging suite. J Neurosurg (2009) 0.83
Integra Foundation Award: Long-term natural history of hemangioblastomas in Von Hippel-Lindau disease: implications for treatment. Clin Neurosurg (2006) 0.83
Single- and multivoxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys (2012) 0.83
Tracking accuracy of T2- and diffusion-weighted magnetic resonance imaging for infusate distribution by convection-enhanced delivery. J Neurosurg (2011) 0.82
Role of edema in peritumoral cyst formation. Neurosurg Focus (2007) 0.82
Progressive peritumoral edema defining the optic fibers and resulting in reversible visual loss. J Neurosurg (2008) 0.82
Sacral hemangioblastoma in a patient with von Hippel-Lindau disease. Case report and review of the literature. Neurosurg Focus (2003) 0.82
Comparison of pulsed versus continuous convective flow for central nervous system tissue perfusion: laboratory investigation. J Neurosurg (2012) 0.82
Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances Radiation Sensitivity, and Shows Combinatorial Efficacy With Bromodomain Inhibition. J Neuropathol Exp Neurol (2015) 0.82
Pathological satiety caused by brainstem hemangioblastoma. J Neurosurg Pediatr (2008) 0.81
Progression of epididymal maldevelopment into hamartoma-like neoplasia in VHL disease. Neoplasia (2008) 0.81